ArticleFrontiers in pharmacology2025
Community pharmacists' engagement with Raqeeb platform: perceptions and implementation challenges toward controlled substance monitoring in Saudi Arabia.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of the Raqeeb narcotic controlling system on tramadol prescriptions in surgical patients: A pre-post implementation study.Saudi journal of anaesthesiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The misuse of narcotic drugs and psychotropic substances (NDPS), especially gabapentinoids, poses a considerable public health concern in Saudi Arabia, leading to the establishment of the Raqeeb platform, a nationwide electronic platform for the real-time monitoring of NDPS prescriptions. This study aimed to assess community pharmacists' perceptions, engagement, and implementation challenges with the Raqeeb platform in order to inform future improvements. Methods: A cross-sectional descriptive study was performed from March to May 2025, targeting licensed community pharmacists in Saudi Arabia. A standardized, self-administered questionnaire, validated by experts and piloted with 15 pharmacists, evaluated knowledge, attitudes, and operational challenges using a five-point Likert scale. Convenience sampling through professional networks and social media produced 270 responses. Data were analyzed with IBM SPSS Statistics version 26, employing descriptive statistics and Cronbach's alpha to assess reliability. Results: Participants (58.1% male, 62.2% PharmD, 78.1% with less than 5 years of experience) demonstrated strong awareness of Raqeeb's objectives and its role in enhancing safety. Most respondents supported mandatory training and nationwide expansion of the platform. However, challenges were reported, including limited integration with pharmacy systems, complexity of the interface, and unavailability of certain controlled drugs. Cronbach's alpha values (0.73-0.87) confirmed the instrument's reliability. Conclusion: Community pharmacists recognize the public health value of Raqeeb; however, its best use has been limited by issues with usability, integration, and training. Addressing these barriers through system integration, structured training, and improved medication availability is essential to strengthening NDPS monitoring and advancing Vision 2030 digital health goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.